On Tuesday, Immunocore Holdings plc ADR (NASDAQ: IMCR) opened lower -3.86% from the last session, before settling in for the closing price of $38.11. Price fluctuations for IMCR have ranged from $23.15 to $40.71 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 20.08%. Company’s average yearly earnings per share was noted 67.03% at the time writing. With a float of $50.08 million, this company’s outstanding shares have now reached $50.47 million.
Immunocore Holdings plc ADR (IMCR) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immunocore Holdings plc ADR is 0.76%, while institutional ownership is 97.66%. The most recent insider transaction that took place on Dec 04 ’25, was worth 1,261,789. In this transaction HEAD OF R&D of this company sold 31,341 shares at a rate of $40.26, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 05 ’25, when Company’s HEAD OF R&D sold 572 for $40.14, making the entire transaction worth $22,960. This insider now owns 0 shares in total.
Immunocore Holdings plc ADR (IMCR) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.47 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.2) by -0.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 67.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.48% during the next five years compared to 20.08% growth over the previous five years of trading.
Immunocore Holdings plc ADR (NASDAQ: IMCR) Trading Performance Indicators
Check out the current performance indicators for Immunocore Holdings plc ADR (IMCR). In the past quarter, the stock posted a quick ratio of 5.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.87. Likewise, its price to free cash flow for the trailing twelve months is 646.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Immunocore Holdings plc ADR (IMCR)
Looking closely at Immunocore Holdings plc ADR (NASDAQ: IMCR), its last 5-days average volume was 0.31 million, which is a drop from its year-to-date volume of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 41.52%.
During the past 100 days, Immunocore Holdings plc ADR’s (IMCR) raw stochastic average was set at 60.11%, which indicates a significant increase from 17.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.78 in the past 14 days, which was higher than the 1.52 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.16, while its 200-day Moving Average is $32.79. However, in the short run, Immunocore Holdings plc ADR’s stock first resistance to watch stands at $37.95. Second resistance stands at $39.25. The third major resistance level sits at $39.96. If the price goes on to break the first support level at $35.94, it is likely to go to the next support level at $35.23. Should the price break the second support level, the third support level stands at $33.93.
Immunocore Holdings plc ADR (NASDAQ: IMCR) Key Stats
There are currently 50,530K shares outstanding in the company with a market cap of 1.85 billion. Presently, the company’s annual sales total 310,200 K according to its annual income of -51,090 K. Last quarter, the company’s sales amounted to 103,690 K and its income totaled -180 K.
